P. Whelton
Journal of the American Medical Association (JAMA) · 2001–2021
A researcher in the Science corpus: 22 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from P. Whelton's perspective
Ordered by how strongly the researchers P. Whelton trusts endorse each paper. Same corpus, a different order for every researcher.
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
- Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
- Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. (Journal of the American Medical Association (JAMA))
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (The Lancet)
- The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. (Journal of the American College of Cardiology)
- Global Estimates and Long-Term Trends of Fine Particulate Matter Concentrations (1998-2018). (Environmental Science and Technology)
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (The Lancet)
- Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. (Journal of the American Medical Association (JAMA))
- Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. (Kidney International)
- Effect of lipid reduction on the progression of renal disease: a meta-analysis. (Kidney International)
Their papers
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) — 619 citations
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 (2020) — 9,012 citations
- HIGH BLOOD PRESSURE AND CARDIOVASCULAR DISEASE (2019) — 1,385 citations
- Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia (2019) — 1,034 citations
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) — 1,758 citations
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) — 2,737 citations
- Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline (2017) — 748 citations
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control. (2016) — 1,164 citations
- Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. (2016) — 1,186 citations
- Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) (2007) — 1,231 citations
- Global burden of hypertension: analysis of worldwide data. (2005) — 8,525 citations
- Major causes of death among men and women in China. (2005) — 1,191 citations
- Prevalence of the metabolic syndrome and overweight among adults in China. (2005) — 955 citations
- Worldwide prevalence of hypertension: a systematic review (2004) — 1,279 citations
- The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults (2004) — 1,357 citations
- Prevalence, Awareness, Treatment, and Control of Hypertension in China (2002) — 610 citations
- Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. (2002) — 855 citations
- Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2002) — 5,360 citations
- Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. (2002) — 1,623 citations
- Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. (2002) — 1,068 citations